Phase 2, Multi-Center, Open-Label, Single-Dose, Single Arm, In-Clinic Study to Evaluate the Actual Human Use of Methotrexate Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device in Adult Patients With Rheumatoid Arthritis
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2014
At a glance
- Drugs Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Antares Pharma
- 25 Sep 2012 Results have been reported in an Antares Pharma media release.
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2012 Profile updated with data presented in an Antares Pharma media release.